Financials Cleopatra Hospitals Group S.A.E.

Equities

CLHO

EGS729J1C018

Healthcare Facilities & Services

End-of-day quote Egyptian Exchange 06:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
6.33 EGP -2.91% Intraday chart for Cleopatra Hospitals Group S.A.E. -5.52% +34.11%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 9,648 7,616 7,784 7,685 6,822 9,150 - -
Enterprise Value (EV) 1 8,865 7,076 7,210 7,865 6,822 10,696 10,550 9,660
P/E ratio 43.1 x 31.7 x 20.3 x 26.1 x 21.5 x 17.8 x 14.3 x 10.4 x
Yield - - - - - - - -
Capitalization / Revenue 5.37 x 3.83 x 3.05 x 2.94 x 1.9 x 2.05 x 1.64 x 1.3 x
EV / Revenue 4.93 x 3.56 x 2.83 x 3.01 x 1.9 x 2.39 x 1.89 x 1.37 x
EV / EBITDA 25.6 x 13.1 x 9.45 x 11.1 x 8.63 x 9.74 x 7.51 x 5.7 x
EV / FCF 121 x -30 x 19.7 x - - -67.3 x 129 x 18.5 x
FCF Yield 0.83% -3.33% 5.08% - - -1.49% 0.77% 5.41%
Price to Book 5.27 x 3.69 x 3.81 x 4.53 x - 3.42 x 2.83 x 2.29 x
Nbr of stocks (in thousands) 1,600,000 1,600,000 1,582,082 1,444,464 1,445,434 1,445,434 - -
Reference price 2 6.030 4.760 4.920 5.320 4.720 6.330 6.330 6.330
Announcement Date 3/12/20 3/21/21 3/20/22 3/20/23 3/17/24 - - -
1EGP in Million2EGP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,798 1,990 2,549 2,614 3,595 4,467 5,570 7,036
EBITDA 1 346.1 539.6 763.2 709.3 790.7 1,098 1,405 1,694
EBIT 1 281.1 349.5 509.5 444.1 650.8 901.7 1,114 1,368
Operating Margin 15.63% 17.57% 19.99% 16.99% 18.1% 20.19% 20.01% 19.44%
Earnings before Tax (EBT) 1 367.5 396.2 534.6 449.7 609.1 813 890 -
Net income 1 257.4 286.9 387.2 325.8 418.2 524 639 801
Net margin 14.32% 14.42% 15.19% 12.46% 11.63% 11.73% 11.47% 11.38%
EPS 2 0.1400 0.1500 0.2420 0.2036 0.2200 0.3564 0.4432 0.6092
Free Cash Flow 1 73.17 -235.9 366 - - -159 81.7 523
FCF margin 4.07% -11.86% 14.36% - - -3.56% 1.47% 7.43%
FCF Conversion (EBITDA) 21.14% - 47.96% - - - 5.81% 30.88%
FCF Conversion (Net income) 28.42% - 94.52% - - - 12.79% 65.29%
Dividend per Share - - - - - - - -
Announcement Date 3/12/20 3/21/21 3/20/22 3/20/23 3/17/24 - - -
1EGP in Million2EGP
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q3 2023 Q4 2024 Q1
Net sales 1 - 1,063 1,108
EBITDA 1 - 194.4 276
EBIT - - -
Operating Margin - - -
Earnings before Tax (EBT) - - -
Net income 1 119.7 107.2 139
Net margin - 10.08% 12.55%
EPS 0.0900 - -
Dividend per Share - - -
Announcement Date 11/26/23 3/17/24 -
1EGP in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - 181 - 1,546 1,400 510
Net Cash position 1 783 540 574 - - - - -
Leverage (Debt/EBITDA) - - - 0.255 x - 1.408 x 0.9965 x 0.3014 x
Free Cash Flow 1 73.2 -236 366 - - -159 81.7 523
ROE (net income / shareholders' equity) 15% 14.7% 17.4% 15.3% - 19.7% 19.1% 24.4%
ROA (Net income/ Total Assets) 10.4% 10.5% 12.5% 9.7% - 10% 9.34% -
Assets 1 2,483 2,725 3,108 3,358 - 5,240 6,842 -
Book Value Per Share 2 1.140 1.290 1.290 1.170 - 1.850 2.230 2.770
Cash Flow per Share 2 0.2600 0.0900 0.4100 0.2000 - 0.5000 0.7500 0.9700
Capex 1 349 408 282 332 - 993 992 -
Capex / Sales 19.43% 20.5% 11.07% 12.69% - 22.23% 17.81% -
Announcement Date 3/12/20 3/21/21 3/20/22 3/20/23 3/17/24 - - -
1EGP in Million2EGP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
6.33 EGP
Average target price
7.54 EGP
Spread / Average Target
+19.12%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CLHO Stock
  4. Financials Cleopatra Hospitals Group S.A.E.